Zhang X - Search Results

1

Bioisosteric replacement strategy leads to novel DNA gyrase B inhibitors with improved potencies and properties.

Xue W, Zuo X, Zhao X, Wang X, Zhang X, Xia J, Cheng M, Yang H. Xue W, et al. Among authors: zhang x. Bioorg Chem. 2024 Jun;147:107314. doi: 10.1016/j.bioorg.2024.107314. Epub 2024 Apr 3. Bioorg Chem. 2024. PMID: 38581967

2

Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer.

Wang K, Ye K, Zhang X, Wang T, Qi Z, Wang Y, Jiang S, Zhang K. Wang K, et al. Among authors: zhang k, zhang x. J Med Chem. 2023 Jan 12;66(1):1027-1047. doi: 10.1021/acs.jmedchem.2c01954. Epub 2023 Jan 3. J Med Chem. 2023. PMID: 36595482

3

Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.

Zhou L, Ye X, Wang K, Shen H, Wang T, Zhang X, Jiang S, Xiao Y, Zhang K. Zhou L, et al. Among authors: zhang k, zhang x. Bioorg Chem. 2023 Sep;138:106682. doi: 10.1016/j.bioorg.2023.106682. Epub 2023 Jun 16. Bioorg Chem. 2023. PMID: 37339563

4

Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).

Wang T, Wang K, Zhang Y, Zhang K, Cai S, Jiang S, Xiao Y, Zhang X. Wang T, et al. Among authors: zhang k, zhang x, zhang y. J Med Chem. 2023 Sep 14;66(17):11881-11892. doi: 10.1021/acs.jmedchem.3c00484. Epub 2023 Aug 18. J Med Chem. 2023. PMID: 37594853

5

Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases.

Shi C, Zhang X, Chi X, Zhou YR, Lyu W, Gao T, Zhou J, Chen Y, Yi C, Sun X, Zhang L, Liu Z. Shi C, et al. Among authors: zhang l, zhang x. Eur J Med Chem. 2023 Nov 15;260:115784. doi: 10.1016/j.ejmech.2023.115784. Epub 2023 Sep 1. Eur J Med Chem. 2023. PMID: 37672931

6

Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy.

Wang K, Zhang X, Cheng Y, Qi Z, Ye K, Zhang K, Jiang S, Liu Y, Xiao Y, Wang T. Wang K, et al. Among authors: zhang k, zhang x. J Med Chem. 2023 Dec 28;66(24):16807-16827. doi: 10.1021/acs.jmedchem.3c01534. Epub 2023 Dec 18. J Med Chem. 2023. PMID: 38109261

7

Scaffold hopping-driven optimization for the identification of NLRP3 inhibitors as potential gout therapeutics.

Shi C, Lyu W, Yu J, Chen Y, Xiu S, Zhang X, Zhang L, Liu Z. Shi C, et al. Among authors: zhang l, zhang x. Eur J Med Chem. 2024 Dec 5;279:116881. doi: 10.1016/j.ejmech.2024.116881. Epub 2024 Sep 18. Eur J Med Chem. 2024. PMID: 39316843

8

NSD3: Advances in cancer therapeutic potential and inhibitors research.

Xiu S, Chi X, Jia Z, Shi C, Zhang X, Li Q, Gao T, Zhang L, Liu Z. Xiu S, et al. Among authors: zhang l, zhang x. Eur J Med Chem. 2023 Aug 5;256:115440. doi: 10.1016/j.ejmech.2023.115440. Epub 2023 May 9. Eur J Med Chem. 2023. PMID: 37182335 Review.

9

Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors.

Zhang K, Ye K, Tang H, Qi Z, Wang T, Mao J, Zhang X, Jiang S. Zhang K, et al. Among authors: zhang x. J Med Chem. 2023 Apr 13;66(7):4378-4416. doi: 10.1021/acs.jmedchem.2c01800. Epub 2023 Mar 23. J Med Chem. 2023. PMID: 36951608 Review.

10

Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).

Zhou L, Yang J, Zhang K, Wang T, Jiang S, Zhang X. Zhou L, et al. Among authors: zhang k, zhang x. J Med Chem. 2024 Jan 25;67(2):816-837. doi: 10.1021/acs.jmedchem.3c01361. Epub 2024 Jan 5. J Med Chem. 2024. PMID: 38181380 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184,017 results

Search Page

Filters